Pump prime aprotinin fails to limit proinflammatory cytokine release after coronary artery bypass surgery

Scandinavian Cardiovascular Journal

Volumn 35, Issue 1, 2001, Pages 50-54

  Wei, Minxin ^a   Kuukasjärvi, Pekka ^b   Laurikka, Jari ^c   Pehkonen, Erkki ^c   Kaukinen, Seppo ^a   Laine, Seppo ^a   Tarkka, Matti ^a  

^a Division of Cardiothoracic Surgery   (Finland)

^b Department of Anesthesia and Intensive Care ^*  (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aprotinin; Coronary artery bypass grafting; Cytokines

Indexed keywords

APROTININ; CREATINE KINASE MB; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ELECTIVE SURGERY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INFUSION PUMP; LEUKOCYTE COUNT; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035044288     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/140174301750101528     Document Type: Article

References (20)

1. Jansen NJ. van Oeveren W, Ou YJ. van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744-748.
2. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108; 626-635.
3. Hill GE. Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylpredmisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995; 110: 1658-1662.
4. Steinberg BM, Grossi EA, Schwartz DS, et al. Heparin bonding of bypass circuits reduces cytokine release during CPB. Ann Thorac Surg 1995; 60: 525529.
5. Journois D, Fouard P, Greeley WJ, Mauriat P. Vouhe P, Safran D. Hemofiltration during CPB in pédiatrie cardiac surgery: effects on hemostasis. cytokines, and complement components. Anesthesiology 1994; 81: 1181-1189.
6. Bidstrup BP, Harrison J, Royston D, Taylor KM. Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971-976.
7. Hill GE. Pohorecki R. Alonso A, Rennard SI. Robbins RA. Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulinonary bypass. Anesth Analg 1996; 83: 696-700.
8. Lemmer Jr JH. Dilling EW, Morton JR. et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. Ann Thorac Surg 1996; 62: 1659-1667.
9. Wan S, LeClerc JL. Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-276.
10. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S. Elliot! M. IL 8 release and neutrophil degranulation after pédiatrie cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-241.
11. Kukielka GL, Smith CW. LaRosa GJ, et al. IL-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995; 95: 89-KB.
12. Leeuwenberg JF, Jeunhomme TM, Buurman WA. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994; 152: 4036-4043.
13. Hill GE, Diego RP, Stammers AH, Huffman SM, Pohorecki R. Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations. Ann Thorac Surg 1998; 65: 66-69.
14. Royston D. Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors. Int J Cardiol 1996; 53 Suppl: S11-37.
15. Ashraf S, Tian Y, Cowan D, et al. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg 1997; 63: 68-73.
16. Karube N, Adachi R, Ichikawa Y, Kosuge T, Yama/aki l, Soina T. Measurement of eytokine levels by coronary sinus blood sampling during cardiac surgery with cardiopulmonary bypass. ASA1O J 1996; 42: M787-791.
17. Liebold A, Keyl C, Birnbaum DE. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg 1999; 15: 340-345.
18. Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993; 55: 1033-1041.
19. Alonso A, Whitten CW. Hill GE. Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophil GDI Ib up-regulation. Ann Thorac Surg 1999; 67: 392-395.
20. Primack C, Walenga JM, Koza MJ, Shankey TV, Pifarre R. Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations. Ann Thorac Surg 1996; 61: 1188-1193.